RDNT - RadNet, Inc.
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $0.19
|
Rev Est: $515.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$92.25
DETAILS
HIGH:
$95.00
LOW:
$90.00
MEDIAN:
$92.00
CONSENSUS:
$92.25
UPSIDE:
36.08%
Market Cap:
5.25B
Volume:
1,063,903
Avg Volume:
821,983
52 Week Range:
45.001-85.84
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.49
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
11,000
IPO Date:
1997-01-03
EPS (TTM):
0.04
P/E Ratio:
1826.32
Revenue (TTM):
1.83B
Total Assets:
3.29B
Total Debt:
1.73B
Cash & Equiv:
740.02M
Rev Growth (5Y):
9.6%
EPS Growth (5Y):
-39.5%
FCF Growth (5Y):
71.6%
ROCE:
4.4%
Debt/Equity:
1.92
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-09 | $0.20 | $0.22 | -10.3% | $522.9M | $494.5M | +5.7% |
| 2025-08-10 | $0.31 | $0.17 | +82.4% | $498.2M | $493.5M | +1.0% |
| 2025-05-11 | $-0.35 | $-0.17 | -105.9% | $471.4M | $443.0M | +6.4% |
| 2025-02-27 | $0.22 | $0.21 | +4.8% | $477.1M | $459.4M | +3.8% |
| 2024-11-10 | $0.18 | $0.14 | +32.5% | $461.1M | $433.9M | +6.3% |
| 2024-08-07 | $0.16 | $0.16 | 0.0% | $459.7M | $438.5M | +4.8% |
| 2024-05-08 | $0.07 | $-0.09 | +177.8% | $431.7M | $421.7M | +2.4% |
| 2024-02-29 | $0.20 | $0.11 | +81.8% | $420.4M | $420.9M | -0.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.83B | 1.62B | 1.43B | 1.32B | 1.07B | 1.15B | 975.15M | 922.19M | 884.53M | 809.63M | 717.57M | 702.99M |
| Net Income | 2.79M | 3.04M | 10.65M | 24.73M | (14.84M) | 14.76M | 32.24M | 53,000 | 7.23M | 7.71M | 1.38M | 2.12M |
| EPS | 0.04 | 0.05 | 0.19 | 0.47 | -0.29 | 0.47 | 0.67 | 0.00 | 0.16 | 0.18 | 0.03 | 0.05 |
| Total Assets | 3.29B | 2.69B | 2.43B | 2.06B | 1.79B | 1.65B | 1.11B | 868.98M | 849.48M | 838.43M | 740.68M | 722.58M |
| Total Debt | 1.73B | 1.49B | 1.51B | 1.40B | 1.18B | 1.25B | 672.28M | 612.99M | 638.73M | 640.73M | 597.61M | 581.63M |
| Cash & Equivalents | 740.02M | 342.57M | 127.83M | 134.61M | 102.02M | 40.16M | 10.39M | 51.32M | 20.64M | 446,000 | 307,000 | 8.41M |
| Operating Cash Flow | 233.02M | 220.86M | 146.42M | 149.49M | 233.76M | 104.32M | 116.75M | 141.19M | 91.60M | 67.04M | 61.00M | 66.42M |
| Free Cash Flow | 44.95M | 44.26M | (103.00M) | (71.20M) | 108.32M | 3.02M | (28.62M) | 52.24M | 25.71M | (66.72M) | 9.84M | 10.58M |
| FCF per Share | 0.62 | 0.70 | -1.83 | -1.36 | 2.13 | 0.06 | -0.59 | 1.11 | 0.56 | -1.52 | 0.24 | 0.27 |
| Book Value | 902.31M | 630.70M | 333.00M | 228.90M | 165.74M | 151.69M | 127.18M | 61.56M | 48.49M | 32.58M | 5.36M | (80,000) |
| Cash & ST Investments | 740.02M | 342.57M | 127.83M | 134.61M | 102.02M | 40.16M | 10.39M | 51.32M | 20.64M | 446,000 | 307,000 | 8.41M |
| ROC Equity | 0.00 | 0.00 | 0.03 | 0.11 | -0.09 | 0.10 | 0.25 | 0.00 | 0.15 | 0.24 | 0.26 | N/A |